Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer - report on clinical outcome and dose to critical organs

Radiotherapy and Oncology

Volumn 87, Issue 1, 2008, Pages 24-28

  Ng, Alice W Y ^a   Tung, Stewart Y ^a   Wong, Victy Y W ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Dose escalation; Dose to normal tissue; Non small cell lung cancer; Stage I; Stereotactic radiotherapy; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CLINICAL ARTICLE; FEMALE; HUMAN; HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY; INOPERABLE CANCER; INOPERABLE LUNG NON SMALL CELL CANCER; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIOTHERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; STEREOTAXIC TECHNIQUES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 41849140779     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.02.015     Document Type: Article

References (22)

1. Martini N., Bains M.S., Burt M.E., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109 (1995) 120-129
2. Sawada S., Komori E., Yamashita M., et al. Comparison in prognosis after VATS lobectomy and open lobectomy for stage I lung cancer - retrospective analysis focused on a histological subgroup. Surg Endosc 21 (2007) 1607-1611
3. Sugi K., Kaneda Y., and Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J Surg 24 (2000) 27-31
4. Morita K., Fuwa N., Suzuki Y., et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiother Oncol 42 (1997) 31-36
5. Sibley G.S., Jamieson T.A., Marks L.B., et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiot Oncol Biol Phys 40 (1998) 149-154
6. Blomgren H., Lax I., Goeransson H., et al. Radiosurgery for tumor in the body: clinical experience using a new methods. J Radiosurg 1 (1998) 63-74
7. Perez C.A., Stanley K., Rubin P., et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-small cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group. Cancer 45 (1988) 2744-2753
8. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma. Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
9. McGarry R.C., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiot Oncol Biol Phys 63 (2005) 1010-1015
10. Wulf J., Baier K., Mueller G., and Flentje M.P. Dose-response in stereotactic irradiation of lung tumor. Radiother Oncol 77 (2005) 83-87
11. Onimaru R., Shirato H., Shimizu S., et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiot Oncol Biol Phys 56 (2003) 126-135
12. Wulf J., Hädinger U., Oppitz, et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177 (2001) 645-655 Abstract
13. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiot Oncol Biol Phys 21 (1991) 109-122
14. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: a 5-year experience. Int J Radiot Oncol Biol Phys 51 (2001) 666-670
15. Fukumoto S., Shirato H., Shimzu S., et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinoma. Cancer 95 (2002) 1546-1553
16. Wulf J., Haedinger U., Oppitz U., et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiot Oncol Biol Phys 60 (2004) 186-196
17. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiot Oncol Biol Phys 63 (2005) 1427-1431
18. Nyman J., Johansson K.A., and Hultén U. Stereotactic hypofractionated radiotherapy of stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 51 (2006) 97-103
19. Bergman B., Chevalier T.L., Pignon J.P., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Eng J Med 350 (2004) 351-360
20. Winton T., Livingston R., Johnson D., et al. Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer. N Eng J Med 352 (2005) 2589-2597
21. Douillard J.Y., Rosell R., Lena M.E., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 7 (2006) 719-727
22. Hoyer M., Roed H., Hansen A.T., et al. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Radiot Oncol Biol Phys 66 (2006) S128-S135